|
Free Research Articles
Citations 61-70 of 789 total displayed.
|
Past content
(since May 2004):
|
Minimal residual disease levels assessed by NPM1 mutation–specific RQ-PCR provide important prognostic information in AML
- Susanne Schnittger, Wolfgang Kern, Claudia Tschulik, Tamara Weiss, Frank Dicker, Brunangelo Falini, Claudia Haferlach, and Torsten Haferlach
Blood 2009; 114: 2220-2231.
[Abstract]
[Full text]
[PDF]
Chronic myeloid leukemia (CML) with P190BCR-ABL: analysis of characteristics, outcomes, and prognostic significance
- Dushyant Verma, Hagop M. Kantarjian, Dan Jones, Rajyalakshmi Luthra, Gautam Borthakur, Srdan Verstovsek, Mary Beth Rios, and Jorge Cortes
Blood 2009; 114: 2232-2235.
[Abstract]
[Full text]
[PDF]
Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members
- Astrid G. S. van Halteren, Ewa Jankowska-Gan, Antoinette Joosten, Els Blokland, Jos Pool, Anneke Brand, William J. Burlingham, and Els Goulmy
Blood 2009; 114: 2263-2272.
[Abstract]
[Full text]
[PDF]
Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival
- Nathalie A. Johnson, Kerry J. Savage, Olga Ludkovski, Susana Ben-Neriah, Ryan Woods, Christian Steidl, Martin J. S. Dyer, Reiner Siebert, John Kuruvilla, Richard Klasa, Joseph M. Connors, Randy D. Gascoyne, and Douglas E. Horsman
Blood 2009; 114: 2273-2279.
[Abstract]
[Full text]
[PDF]
Allogeneic disparities in immunoglobulin-like transcript 5 induce potent antibody responses in hematopoietic stem cell transplant recipients
- Katharina Pfistershammer, Anita Lawitschka, Christoph Klauser, Judith Leitner, Roman Weigl, Mirjam H. M. Heemskerk, Winfried F. Pickl, Otto Majdic, Georg A. Böhmig, Gottfried F. Fischer, Hildegard T. Greinix, and Peter Steinberger
Blood 2009; 114: 2323-2332.
[Abstract]
[Full text]
[PDF]
How I treat the antiphospholipid syndrome
- Bill Giannakopoulos and Steven A. Krilis
Blood 2009; 114: 2020-2030.
[Abstract]
[Full text]
[PDF]
A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families
- Willem M. Lijfering, Nic J. G. M. Veeger, Saskia Middeldorp, Karly Hamulyák, Martin H. Prins, Harry R. Büller, and Jan van der Meer
Blood 2009; 114: 2031-2036.
[Abstract]
[Full text]
[PDF]
Long-term outcome of patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors after imatinib failure is predicted by the in vitro sensitivity of BCR-ABL kinase domain mutations
- Elias Jabbour, Daniel Jones, Hagop M. Kantarjian, Susan O'Brien, Constantine Tam, Charles Koller, Jan A. Burger, Gautam Borthakur, William G. Wierda, and Jorge Cortes
Blood 2009; 114: 2037-2043.
[Abstract]
[Full text]
[PDF]
A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425
- Cindy L. Schwartz, Louis S. Constine, Doojduen Villaluna, Wendy B. London, Robert E. Hutchison, Richard Sposto, Steven E. Lipshultz, Charles S. Turner, Pedro A. deAlarcon, and Allen Chauvenet
Blood 2009; 114: 2051-2059.
[Abstract]
[Full text]
[PDF]
F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma
- Twyla B. Bartel, Jeff Haessler, Tracy L. Y. Brown, John D. Shaughnessy, Jr, Frits van Rhee, Elias Anaissie, Terri Alpe, Edgardo Angtuaco, Ronald Walker, Joshua Epstein, John Crowley, and Bart Barlogie
Blood 2009; 114: 2068-2076.
[Abstract]
[Full text]
[PDF]
|
|
